CoreCap Advisors’s Jazz Pharmaceuticals JAZZ Stock Holding History

CoreCap Advisors’s Portfolio JAZZ Stock Details JAZZ Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q3	$2.55K	Hold	11	–	–	﹤0.01%	2433
2026 Q2	$2.65K	Sell	11 -4	-27%	-$876	﹤0.01%	2466
2026 Q1	$2.84K	Hold	15	–	–	﹤0.01%	2327
2025 Q4	$2.55K	Buy	15 +8	+114%	+$1.23K	﹤0.01%	2408
2025 Q3	$923	Hold	7	–	–	﹤0.01%	2495
2025 Q2	$743	Hold	7	–	–	﹤0.01%	2461
2025 Q1	$869	Hold	7	–	–	﹤0.01%	2555
2024 Q4	$862	Hold	7	–	–	﹤0.01%	2399
2024 Q3	$780	Sell	7 -6	-46%	-$657	﹤0.01%	2301
2024 Q2	$1.39K	Sell	13 -2	-13%	-$220	﹤0.01%	1367
2024 Q1	$1.81K	Buy	+15	New	+$1.84K	﹤0.01%	2143
2022 Q4	$1.43K	Buy	+9	New	+$1.32K	﹤0.01%	2000
2022 Q3	–	Sell	-9	Closed	-$1K	–	1324
2022 Q2	$1K	Buy	+9	New	+$1.38K	﹤0.01%	2005
2022 Q1	–	Sell	-9	Closed	-$1K	–	1324
2021 Q4	$1K	Buy	+9	New	+$1.18K	﹤0.01%	2157

Other funds holding JAZZ

AssetMark Inc Concord, California $59.5B AUM 15.92% 1-Year Est. Return

Polaris Capital Management Boston, Massachusetts $953M AUM 27.74% 1-Year Est. Return

Argent Capital Management St Louis, Missouri $3.14B AUM 31.36% 1-Year Est. Return

KBC Group Brussels, Belgium $47.9B AUM 37.61% 1-Year Est. Return

Wedge Capital Management Charlotte, North Carolina $5.72B AUM 38.26% 1-Year Est. Return

Perpetual Ltd Sydney, New South Wales, Australia $6.57B AUM 14.15% 1-Year Est. Return

Robeco Institutional Asset Management Rotterdam, Netherlands $83.2B AUM 35.34% 1-Year Est. Return

Hennion & Walsh Asset Management Parsippany, New Jersey $3.42B AUM 25.82% 1-Year Est. Return

New York State Teachers Retirement System (NYSTRS) Albany, New York $52.9B AUM 36.03% 1-Year Est. Return

State of Alaska Department of Revenue Juneau, Alaska $9.6B AUM 34.67% 1-Year Est. Return

CoreCap Advisors's JAZZ Position: Q3 2026 in Review

CoreCap Advisors held its Jazz Pharmaceuticals (JAZZ) position steady in Q3 2026 at 11 shares worth $2.55K. The position accounts for ﹤0.01% of the portfolio, ranked #2433.

CoreCap Advisors first reported a position in JAZZ in Q4 2021 and has held it in 14 quarters since. The position peaked at $2.84K in Q1 2026. 119 funds tracked by Wall St. Rank hold JAZZ as of Q3 2026.

CoreCap Advisors held 11 shares of Jazz Pharmaceuticals worth $2.55K as of Q3 2026.
CoreCap Advisors left its Jazz Pharmaceuticals share count unchanged in Q3 2026.
Jazz Pharmaceuticals made up ﹤0.01% of CoreCap Advisors's portfolio in Q3 2026, its #2433 holding.
CoreCap Advisors first reported a position in Jazz Pharmaceuticals in Q4 2021 and has held it in 14 quarters since.
CoreCap Advisors's Jazz Pharmaceuticals position peaked at $2.84K in Q1 2026.
119 funds tracked by Wall St. Rank held Jazz Pharmaceuticals as of Q3 2026.

Based on CoreCap Advisors's 13F filing for Q3 2026, filed 8 Oct 2026.